1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with mrs 1845 in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (mrs 1845) | Trials (mrs 1845) | Recent Studies (post-2010) (mrs 1845) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 17 | 0 | 5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dransfield, I; Haslett, C; McMeekin, SR; Rossi, AG; Walker, TR | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and mrs 1845
Article | Year |
---|---|
E-selectin permits communication between PAF receptors and TRPC channels in human neutrophils.
Topics: Calcium; Calcium Signaling; CD18 Antigens; Cell Adhesion; E-Selectin; Endothelium, Vascular; Humans; Inositol 1,4,5-Trisphosphate; Neutrophils; Nitrendipine; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptor Aggregation; Receptors, G-Protein-Coupled; src-Family Kinases; TRPC Cation Channels; TRPC6 Cation Channel | 2006 |